Want to join the conversation?
Pharmaceutical giant $PFE said that it will acquire $ANAC, a biopharmaceutical company for $99.25 per $ANAC share, in cash, for a total transaction value, net of cash, of approx. $5.2Bil. $ANAC's flagship asset, crisaborole, a non-steroidal topical PDE4 inhibitor with anti-inflammatory properties, is currently under review by the FDA for eczema.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?